Home › Funds › SEIZERT CAPITAL PARTNERS, LLC › UTHR
SEIZERT CAPITAL PARTNERS, LLC position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
SEIZERT CAPITAL PARTNERS, LLC reported holding 72,712 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$39.4M, representing 1.71% of its reported portfolio and ranking #31 among its reported holdings. SEIZERT CAPITAL PARTNERS, LLC has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SEIZERT CAPITAL PARTNERS, LLC's UTHR position evolved
SEIZERT CAPITAL PARTNERS, LLC first disclosed a stake in UTHR in Q3 2023 at 29,158 shares (US$6.6M). The position peaked in Q4 2025 at 145,522 shares, worth US$70.9M. Across 13 filings, SEIZERT CAPITAL PARTNERS, LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 72,712 shares valued at US$39.4M — a reduction of -4,116 shares quarter over quarter.. Notable position changes include a 59% increase in Q3 2024 (shares fell 2% over the following quarter), a 203% increase in Q1 2025 (shares fell 8% over the following quarter), a 28% trim in Q1 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 29.16K | $6.59M | New |
| Q4 2023 | 25.07K | $5.51M | Reduce |
| Q1 2024 | 25.27K | $5.81M | Add |
| Q2 2024 | 24.44K | $7.79M | Reduce |
| Q3 2024 | 38.91K | $13.94M | Add |
| Q4 2024 | 40.22K | $14.19M | Add |
| Q1 2025 | 121.97K | $37.60M | Add |
| Q2 2025 | 125.54K | $36.07M | Add |
| Q3 2025 | 146.99K | $61.62M | Add |
| Q4 2025 | 145.52K | $70.91M | Reduce |
| Q1 2026 | 104.67K | $62.07M | Reduce |
| Q2 2026 | 76.83K | $41.63M | Reduce |
| Q3 2026 | 72.71K | $39.40M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.68M sh · $908.15M · Q3 2026
- ASSETMARK, INC 600.17K sh · $325.23M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on SEIZERT CAPITAL PARTNERS, LLC
FAQ
How long has SEIZERT CAPITAL PARTNERS, LLC held UTHR?
SEIZERT CAPITAL PARTNERS, LLC has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SEIZERT CAPITAL PARTNERS, LLC's current position in UTHR?
As of Q3 2026, SEIZERT CAPITAL PARTNERS, LLC holds 72.71K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $39.40M, representing 1.71% of its reported portfolio and ranking #31.
Has SEIZERT CAPITAL PARTNERS, LLC been buying or selling UTHR?
In the latest 13F filing (Q3 2026), SEIZERT CAPITAL PARTNERS, LLC reduced its position in UTHR. The position peaked in Q4 2025 at 145.52K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.